Hambrecht & Quist Capital Management »

Corbus Pharmaceuticals Hldgs shares owned by Hambrecht & Quist Capital Management

Quarter-by-quarter ownership of Corbus Pharmaceuticals Hldgs (CRBP) shares owned by Hambrecht & Quist Capital Management from 13F filings

Historical chart of Hambrecht & Quist Capital Management investment in Corbus Pharmaceuticals Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Corbus Pharmaceuticals Hldgs held by Hambrecht & Quist Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corbus Pharmaceuticals Hldgs by Hambrecht & Quist Capital Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $40k 5.1k 7.84
2023-03-31 $37k 5.1k 7.27

More positions owned by Hambrecht & Quist Capital Management

Amgen Common (AMGN)
Johnson & Johnson Common (JNJ)
Gilead Sciences Common (GILD)
Regeneron Pharmaceuticals Common (REGN)
Vertex Pharmaceuticals Common (VRTX)
Eli Lilly and Company Common (LLY)
Unitedhealth Group Common (UNH)
Merck & Co Common (MRK)
AbbVie Common (ABBV)
Biogen Common (BIIB)
AstraZeneca Sponsored ADR (AZN)
Illumina Common (ILMN)
Abbott Laboratories Common (ABT)
Pfizer Common (PFE)
Thermo Fisher Scientific Common (TMO)

View all positions for Hambrecht & Quist Capital Management

Top funds holding Corbus Pharmaceuticals Hldgs

Assenagon Asset Management
Ikarian Capital
Vanguard Group
HealthInvest Partners AB
Mirae Asset Global Investments
Royal Bank of Canada
Dimensional Fund Advisors
Cambridge Investment Research Advisors
Cutler
Simplex Trading
JTC Employer Solutions Trustee
Citigroup
Jpmorgan Chase & Co
UBS Group
Advisor Group Holdings

View all funds holding Corbus Pharmaceuticals Hldgs